Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. HLN
stocks logo

HLN

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
2.74B
-1.44%
--
--
2.84B
+2.03%
--
--
2.89B
+4.64%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for Haleon plc (HLN) for FY2025, with the revenue forecasts being adjusted by -2.36% over the past three months. During the same period, the stock price has changed by 8.62%.
Revenue Estimates for FY2025
Revise Downward
down Image
-2.36%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-3.17%
In Past 3 Month
Stock Price
Go Up
up Image
+8.62%
In Past 3 Month
1 Analyst Rating
up Image0
Wall Street analysts forecast HLN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLN is 11.51 USD with a low forecast of 11.51 USD and a high forecast of 11.51  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
up Image0
Current: 10.710
sliders
Low
11.51
Averages
11.51
High
11.51
up Image0
Current: 10.710
sliders
Low
11.51
Averages
11.51
High
11.51
Morgan Stanley
Rashad Kawan
Buy
Maintains
$9.9 → $11
2024-09-20
Reason
Morgan Stanley
Rashad Kawan
Price Target
$9.9 → $11
2024-09-20
Maintains
Buy
Reason
Morgan Stanley raised the firm's price target on Haleon to $10.95 from $9.90 and keeps an Overweight rating on the shares. The firm also removed the shares as a Top Pick. As one of the best-performing stocks in European staples year-to-date, Haleon offers less absolute upside from here, the analyst tells investors in a research note. However, the firm continue to favors the company relative to other food alternatives.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Haleon PLC (HLN.N) is 21.83, compared to its 5-year average forward P/E of 16.31. For a more detailed relative valuation and DCF analysis to assess Haleon PLC 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
16.31
Current PE
21.83
Overvalued PE
22.35
Undervalued PE
10.27

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Overvalued
5Y Average EV/EBITDA
13.92
Current EV/EBITDA
15.86
Overvalued EV/EBITDA
14.82
Undervalued EV/EBITDA
13.02

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Overvalued
5Y Average PS
2.70
Current PS
3.25
Overvalued PS
2.95
Undervalued PS
2.45

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 545.97% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

HLN News & Events

Events Timeline

(ET)
2025-01-14
10:39:30
Pfizer to sell 700M ordinary shares of Haleon
select
2024-12-02 (ET)
2024-12-02
06:59:21
Haleon appoints Sta-Romana as Chief Customer Officer for its U.S. business
select
2024-09-30 (ET)
2024-09-30
14:16:43
Pfizer upsizes Haleon offering to 640M shares, Bloomberg says
select
Sign Up For More Events
Sign Up For More Events

News

Preview
6.0
04-10Business Insider
Kepler Capital Reaffirms Their Buy Rating on Haleon PLC (HLN)

  • Analyst Ratings: Kepler Capital analyst Karel Zoete has maintained a Buy rating on Haleon PLC with a price target of p440.00, while Citi's Cedric Besnard also issued a Buy rating; however, Deutsche Bank has a Hold rating on the stock.

  • Company Performance: Haleon PLC reported a quarterly revenue of p2.78 billion and a net profit of p303 million, showing slight growth compared to the previous year, but insider sentiment is negative as more insiders are selling shares.

Preview
8.5
04-10Benzinga
KKR Outbids Competitors To Secure $2.9 Billion Karo Healthcare Takeover

  • KKR Acquires Karo Healthcare: KKR & Co. Inc. has reached an agreement to acquire Swedish consumer health firm Karo Healthcare for approximately 2.65 billion euros, outbidding rival PAI Partners, with the deal expected to close in the coming months pending regulatory approvals.

  • Impact on Healthcare Investments: This acquisition highlights KKR's commitment to healthcare investments despite a slowdown in overall merger activity, and it is anticipated to provide significant returns for EQT, which previously took Karo private and expanded its brand portfolio.

Preview
9.5
04-01NASDAQ.COM
Haleon Q1 Revenues Down, Organic Revenues Rise; Backs FY25 Outlook

  • First Quarter Performance: Haleon Plc reported a 2.3% decline in revenues to £2.85 billion, despite a 3.5% organic revenue growth driven by price increases and volume/mix improvements across all regions.

  • Future Outlook: The company anticipates organic revenue growth of 4% to 6% for fiscal 2025, with expectations for stronger performance in the second half of the year, while acknowledging ongoing macroeconomic challenges.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Haleon PLC (HLN) stock price today?

The current price of HLN is 10.71 USD — it has decreased -0.28 % in the last trading day.

arrow icon

What is Haleon PLC (HLN)'s business?

Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

arrow icon

What is the price predicton of HLN Stock?

Wall Street analysts forecast HLN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLN is 11.51 USD with a low forecast of 11.51 USD and a high forecast of 11.51 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Haleon PLC (HLN)'s revenue for the last quarter?

Haleon PLC revenue for the last quarter amounts to 2.85B USD, decreased -2.26 % YoY.

arrow icon

What is Haleon PLC (HLN)'s earnings per share (EPS) for the last quarter?

Haleon PLC. EPS for the last quarter amounts to USD, decreased -100.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Haleon PLC (HLN)'s fundamentals?

The market is revising Downward the revenue expectations for Haleon plc (HLN) for FY2025, with the revenue forecasts being adjusted by -2.36% over the past three months. During the same period, the stock price has changed by 8.62%.
arrow icon

How many employees does Haleon PLC (HLN). have?

Haleon PLC (HLN) has 24622 emplpoyees as of May 13 2025.

arrow icon

What is Haleon PLC (HLN) market cap?

Today HLN has the market capitalization of 48.27B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free